| Structure | Chemical Name | CAS | MF |
|
6,8-Dichloro-3H-pyrido[3,4-d]pyrimidin-4-one
|
2368909-25-3
|
C7H3Cl2N3O
|
|
2-Bromo-3-chloro-6-fluoro-4-methyl-benzaldehyde
|
2368909-40-2
|
C8H5BrClFO
|
|
1H-Indazole, 4-bromo-5-chloro-6-methyl-
|
2368909-41-3
|
C8H6BrClN2
|
|
4-Bromo-5-chloro-6-methyl-1-(tetrahydro-pyran-2-yl)-1H-indazole
|
2368909-42-4
|
C13H14BrClN2O
|
|
2-bromo-4-chloro-6-fluoro-3-methylaniline
|
2368909-46-8
|
C7H6BrClFN
|
|
3-Bromo-1-chloro-5-fluoro-4-iodo-2-methyl-benzene
|
2368909-47-9
|
C7H4BrClFI
|
|
2-bromo-4-chloro-6-fluoro-3-methylbenzaldehyde
|
2368909-48-0
|
C8H5BrClFO
|
|
1H-Indazole, 4-bromo-6-chloro-5-methyl-
|
2368909-49-1
|
C8H6BrClN2
|
|
5-Chloro-6-fluoro-1-(tetrahydro-pyran-2-yl)-1H-indazol-4-ol
|
2368909-53-7
|
C12H12ClFN2O2
|
|
Benzenamine, 3-bromo-4-chloro-5-fluoro-2-methyl-
|
2368909-54-8
|
C7H6BrClFN
|
|
1H-Indazole, 4-bromo-5-chloro-6-fluoro-
|
2368909-55-9
|
C7H3BrClFN2
|
|
4-Bromo-5-chloro-6-fluoro-1-(tetrahydro-pyran-2-yl)-1H-indazole
|
2368909-56-0
|
C12H11BrClFN2O
|
|
1-Piperazinecarboxylic acid, 4-(8-bromo-4-quinazolinyl)-, 1,1-dimethylethyl ester
|
2368909-93-5
|
C17H21BrN4O2
|
|
5,6-dichloro-1-[(2R)-tetrahydro-2H-pyran-2-yl]-1 H-indazol-4-ol
|
2368910-17-0
|
C12H12Cl2N2O2
|
|
Pyrido[3,4-d]pyrimidin-4(3H)-one, 6,8-dichloro-2-(methylthio)-
|
2368910-54-5
|
C8H5Cl2N3OS
|
|
1-Piperazinecarboxylic acid, 4-[6,8-dichloro-2-(methylthio)pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester
|
2368910-58-9
|
C17H21Cl2N5O2S
|
|
3-Amino-2-chloro-6-methyl-isonicotinamide
|
2368911-21-9
|
C7H8ClN3O
|
|
1H-Indazole, 4,6-difluoro-1-(tetrahydro-2H-pyran-2-yl)-
|
2368911-29-7
|
C12H12F2N2O
|
|
Oxazole, 2,2′-[(phenylphosphinidene)di-2,1-phenylene]bis[4,5-dihydro-4-(phenylmethyl)-, (4S,4′S)-
|
2368937-52-2
|
C38H33N2O2P
|
|
PROTAC PARP1 degrader
|
2369022-68-2
|
C58H63Cl2N11O10
|
|
2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol hydrochloride
|
2369053-68-7
|
C14H18ClN5O
|
|
Benzaldehyde, 2,6-dimethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
2369068-26-6
|
C15H21BO5
|
|
Propanoic acid, 3-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
|
2369068-42-6
|
C16H14N2O7
|
|
1H-Isoindole-4-carboxaldehyde, 2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-
|
2369068-46-0
|
C14H10N2O5
|
|
HRX-0215
|
2369583-33-3
|
C21H17F2N5O3S
|
|
2-Pyridinamine, 6-chloro-5-iodo-4-methyl-
|
2369616-78-2
|
C6H6ClIN2
|
|
Benzenesulfonamide, 5-[[2-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-4-pyrimidinyl]amino]-2-methyl-
|
2369664-19-5
|
C21H23N7O2S
|
|
Ethanone, 1-?[6,?7-?dichloro-?1,?3,?4,?5-?tetrahydro-?9-?(1-?methyl-?1H-?pyrazol-?3-?yl)?-?2H-?pyrido[4,?3-?b]?indol-?2-?yl]?-?2-?hydroxy-
|
2369751-07-3
|
C17H16Cl2N4O2
|
|
Ethanone, 1-?[9-?(6-?amino-?3-?pyridinyl)?-?6,?7-?dichloro-?1,?3,?4,?5-?tetrahydro-?2H-?pyrido[4,?3-?b]?indol-?2-?yl]?-?2-?hydroxy-
|
2369751-30-2
|
C18H16Cl2N4O2
|
|
2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
|
2369772-10-9
|
C12H19BN2O3
|
|
5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-ethyl-1-piperazinyl)-1-fluoro-
|
2369979-67-7
|
C19H20ClFN4
|
|
5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-ethyl-1-piperazinyl)-4-fluoro-
|
2369979-68-8
|
C19H20ClFN4
|
|
CDK9-IN-7
|
2369981-71-3
|
C29H37N7O2S
|
|
Sunvozertinib
|
2370013-12-8
|
C29H35ClFN7O3
|
|
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-
|
2370013-49-1
|
C29H35ClFN7O3
|
|
Benzenemethanol, 2-amino-4-chloro-5-fluoro-α,α-dimethyl-
|
2370014-05-2
|
C9H11ClFNO
|
|
2-Thiophenecarboxaldehyde, 5-bromo-4-(2-octyldodecyl)-
|
2370860-05-0
|
C25H43BrOS
|
|
PBDB-T-SF
|
2370878-93-4
|
(C68H76F2O2S10)n
|
|
2,6-DBEAQ
|
2370885-20-2
|
C22H20O8
|
|
2,6-DPPEAQ
|
2370885-23-5
|
C20H22O10P2
|
|
[1,1'-Biphenyl]-4-acetonitrile, 4'-(9H-carbazol-9-yl)-
|
2370920-87-7
|
C26H18N2
|
|
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[4-[3-[[4-[[[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethyl]amino]carbonyl]-6-quinolinyl]oxy]propyl]-1-piperazinyl]-2-oxoethyl]-
|
2370952-98-8
|
C40H56N10O10
|
|
(3aR,3a'R,7aR,7a'R)-2,2'-(((2S,4S)-Pentane-2,4-diyl)bis(oxy))bis(1,3-diphenyloctahydro-1H-benzo[d][1,3,2]diazaphosphole)
|
2370958-37-3
|
C41H50N4O2P2
|
|
Carbamic acid, N-[(1S,3R)-3-hydroxycyclopentyl]-N-methyl-, 1,1-dimethylethyl ester
|
2370967-14-7
|
C11H21NO3
|
|
4-Piperidinecarboxamide, 1-methyl-N-(5-phenyl-2-thiazolyl)-
|
2373065-59-7
|
C16H19N3OS
|
|
Propanedinitrile, 2,2'-[[4,4,9,9-tetrakis(4-hexylphenyl)-4,9-dihydro-s-indaceno[1,2-b:5,6-b']dithiophene-2,7-diyl]bis[methylidyne(5,6-difluoro-3-oxo-1H-indene-2,1(3H)-diylidene)]]bis-
|
2373324-10-6
|
C90H78F4N4O2S2
|
|
tert-Butyl 6-(tetramethyl-1,3,2-dioxaborolan-2-yl)hexanoate
|
2373347-25-0
|
C16H31BO4
|
|
(S,R,S)-AHPC-PEG3-Alkyne
|
2374122-30-0
|
C32H44N4O7S
|
|
A 410099.1, amine
|
2374122-37-7
|
C32H50ClN5O5
|
|
5-Chloro-8-iodoimidazo[1,2-c]pyrimidine
|
2374134-99-1
|
C6H3ClIN3
|
|
di-tert-butyl((2S,3S)-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)phosphine oxide
|
2374143-28-7
|
C27H40O4P2
|
|
((2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)di-tert-butylphosphine oxide
|
2374143-29-8
|
C33H40O2P2
|
|
((2S,3S)-4-(benzyloxy)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)di-tert-butylphosphine oxide
|
2374143-30-1
|
C26H38O3P2
|
|
di-tert-butyl((2S,3S)-3-(tert-butyl)-4-phenoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)phosphine oxide
|
2374143-31-2
|
C25H36O3P2
|
|
di-tert-butyl((2S,3S)-3-(tert-butyl)-4-isopropoxy-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)phosphine oxide
|
2374143-32-3
|
C22H38O3P2
|
|
((2S,3S)-4-(tert-butoxy)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)di-tert-butylphosphine oxide
|
2374143-33-4
|
C23H40O3P2
|
|
5-chloro-6-methyl-1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
|
2374152-77-7
|
C19H26BClN2O3
|
|
6-Chloro-5-methyl-1-(tetrahydro-pyran-2-yl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole
|
2374152-83-5
|
C19H26BClN2O3
|
|
1-Azetidinecarboximidamide,3-(dimethylamino)-,hydrochloride (1:2)
|
2374153-24-7
|
C6H15ClN4
|
|
1-(tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-ylboronic acid
|
2374153-25-8
|
C13H14BF3N2O3
|
|
Tenofovir Impurity 1
|
2374212-01-6
|
C17H29N6O5P
|
|
[S(R)]-N-[(S)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide
|
2374225-91-7
|
C43H48NO2PS
|
|
[S(R)]-N-[(S)-(2-methylphenyl)[5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide
|
2374225-98-4
|
C39H40NO2PS
|
|
4(3H)-Quinazolinone, 6-fluoro-2-[(1E)-2-(5-nitro-2-furanyl)ethenyl]-3-phenyl-
|
2374285-52-4
|
C20H12FN3O4
|
|
SIS17
|
2374313-54-7
|
C21H38N2OS
|
|
5-(4-(5-bromothiophen-2-yl)-2,5-bis((2-ethylhexyl)oxy)phenyl)thiophene-2-carbaldehyde
|
2374314-09-5
|
C31H41BrO3S2
|
|
Tofacitinib Impurity 44
|
2374700-39-5
|
C13H19N5
|
|
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
|
2374700-40-8
|
C16H20N6O
|
|
1,3-Benzenedicarboxylic acid, 4,6-di-1H-imidazol-1-yl-
|
2374700-80-6
|
C14H10N4O4
|
|
Etomidate Impurity 15
|
2374709-47-2
|
C16H23NO4
|
|
Baloxavir Marboxil Impurity 19
|
2374735-31-4
|
C27H24FN3O7S
|
|
AKT-IN-3
|
2374740-21-1
|
C23H23Cl2F2N5O3
|
|
4,4,5,5-tetramethyl-2-(3-oxabicyclo[4.1.0]heptan-6-yl)-1,3,2-dioxaborolane
|
2374751-49-0
|
C12H21BO3
|
|
FAPI-4
|
2374782-02-0
|
C40H54F2N10O10
|
|
NTFAPI
|
2374782-03-1
|
C36H47F2N9O8
|
|
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[4-[3-[[4-[[[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]amino]carbonyl]-6-quinolinyl]methylamino]propyl]-1-piperazinyl]-2-oxoethyl]-
|
2374782-04-2
|
C41H57F2N11O9
|
|
(S)-6-[3-(4-Boc-1-piperazinyl)propoxy]-N-[2-(2-cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide
|
2374782-82-6
|
C29H36F2N6O5
|
|
trifluoro(3-oxabicyclo[4.1.0]heptan-6-yl)boranuide
|
2374786-94-2
|
C6H9BF3KO
|
|
CDC25B-IN-1
|
2374831-10-2
|
C20H19NO3
|
|
(5S,5'S)-5,5'-((((5,5'-(2,2'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(3-methoxypyrazine-5,2-diyl))bis(methylene))bis(azanediyl))bis(methylene))bis(pyrrolidin-2-one)
|
2374856-75-2
|
C34H36Cl2N8O4
|
|
2,2'-Bi-1H-imidazole, 4,4',5,5'-tetrahydro-4,4'-bis(1-methylethyl)-1,1'-bis[3-(1-methylethyl)phenyl]-, (4S,4'S)-
|
2374958-79-7
|
C30H42N4
|
|
2,2'-Bi-1H-imidazole, 4,4',5,5'-tetrahydro-4,4'-bis(1-methylethyl)-1,1'-bis(3-methylphenyl)-, (4S,4'S)-
|
2374958-85-5
|
C26H34N4
|
|
2,2'-Bi-1H-imidazole, 1,1'-bis([1,1'-biphenyl]-4-yl)-4,4',5,5'-tetrahydro-4,4'-bis(1-methylethyl)-, (4S,4'S)-
|
2374958-86-6
|
C36H38N4
|
|
2,2'-Bioxazole, 4,4',5,5'-tetrahydro-4,4'-bis(1-methylpropyl)-, (4S,4'S)-
|
2374958-89-9
|
C14H24N2O2
|
|
5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester
|
2375033-26-2
|
C19H21NO5S
|
|
ethyl 2-(4-(sec-butoxy)-3-formylphenyl)-4-methylthiazole-5-
carboxylate
|
2375033-31-9
|
C18H21NO4S
|
|
ethyl 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-
carboxylate
|
2375033-35-3
|
C18H20N2O3S
|
|
Benzenemethanol, 2-[4-amino-6-[[(4-phenoxyphenyl)methyl]amino]-1,3,5-triazin-2-yl]-3-fluoro-
|
2375070-79-2
|
C23H20FN5O2
|
|
CyOH
|
2375085-08-6
|
C31H30NO2+
|
|
Pyrido[2,3-d]pyrimidine-2,7(1H,8H)-dione, 8-cyclopentyl-5-methyl-
|
2375089-01-1
|
C13H15N3O2
|
|
Cyanine5.5 NHS ester
|
2375105-86-3
|
C44H46BF4N3O4
|
|
Fmoc-NH-PEG10-CH2COOH
|
2375105-88-5
|
C37H55NO14
|
|
(2S,3R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(octanoyloxy)butanoic acid
|
2375143-48-7
|
C27H33NO6
|
|
1-(tert-butyl) 3-methyl (S)-3-methylpyrrolidine-1,3-dicarboxylate
|
2375165-13-0
|
C12H21NO4
|
|
3-Oxetanemethanol, α-methyl-, (αS)-
|
2375165-26-5
|
C5H10O2
|
|
3-Oxetanemethanol, α-methyl-, (αR)-
|
2375165-27-6
|
C5H10O2
|
|
(S)-3,3-difluoro-1-methylpiperidin-4-ol
|
2375165-68-5
|
C6H11F2NO
|
|
1-Piperidinecarboxylic acid, 5-amino-2-methyl-, 1,1-dimethylethyl ester, (2S,5S)…
|
2375165-77-6
|
C11H22N2O2
|
|
3,3-difluoro-1-propylpiperidin-4-ol hydrochloride
|
2375193-06-7
|
C8H16ClF2NO
|
|
XRK3F2
|
2375193-43-2
|
C23H24ClF2NO3
|